Atlas Trials

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Clinical trial NCT05797948 · UNKNOWN

Trial details

NCT number
NCT05797948
Sponsor
The First Affiliated Hospital of Soochow University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Start date
2022-07-01
Primary completion
2024-06-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.